Drinking 1 cup of caffeinated coffee a day might help lower a person's risk of recurrent AFib episodes by as much as 39%, a ...
Pokémon phantasmal flames release date is today! Grab a booster pack with new cards and try to pull a Charizard, Or catch 'em ...
Positive randomized 3-month REMAIN-1 Midpoint Cohort data showed single Revitaprocedure maintained weight loss after GLP-1 discontinuation; ...
The ATTD of DM decreased then increased (linear, P = 0.001; quadratic, P = 0.003) as TIU/mg of complete feed increased in the ...
Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...
Medpage Today on MSN
Year in Review: Breast Cancer
The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...
News Medical on MSN
Research spotlight: Trial evaluates a vitamin B3 derivative in people with long COVID
Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in ...
The DESTINY-Breast11 (DB-11) and DESTINY-Breast05 (DB-05) trials, presented at the European Society for Medical Oncology ...
Adults with atrial fibrillation who drank a cup a day of caffeinated coffee were less likely to have recurrent AF or atrial ...
CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...
Absci accelerates ABS-201 in alopecia & endometriosis, targets data by 2027, and refocuses pipeline for value.
The novel extended-release formulation is expected to prevent both acute and delayed CINV for up to 5 days, improving patient compliance and convenience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results